Literature DB >> 21846988

Clinical course of patients with familial early-onset Alzheimer's disease potentially lacking senile plaques bearing the E693Δ mutation in amyloid precursor protein.

Hiroyuki Shimada1, Suzuka Ataka, Takami Tomiyama, Hajime Takechi, Hiroshi Mori, Takami Miki.   

Abstract

BACKGROUND/AIMS: Oligomeric amyloid β (Aβ) is currently considered to induce Alzheimer's disease (AD). We examined 2 patients with familial AD who possessed the Osaka (E693Δ) mutation in amyloid precursor protein. To the best of our knowledge, these patients are the first AD cases presumably affected with Aβ oligomers in the absence of senile plaques, and they support the Aβ oligomer hypothesis.
METHODS: We evaluated the clinical course, neuropsychological data, cerebrospinal fluid biomarker levels, magnetic resonance imaging (MRI) scans, fluorodeoxyglucose-positron emission tomography (PET) scans, and Pittsburgh compound B (PiB)-PET images of these patients.
RESULTS: In the early stages, these patients developed memory disturbances in a similar rate to patients with sporadic AD. Despite their memory disturbances, both patients showed only limited brain atrophy on MRI and little amyloid accumulation on PiB-PET. Subsequent to the development of memory disturbances, both patients suffered from motor dysfunction, probably due to cerebellar ataxia, and, within a few years, the patients fell into an apallic state.
CONCLUSIONS: Familial AD patients with Osaka (E693Δ) mutation show severe dementia, cerebellar ataxia, and gait disturbances. 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21846988     DOI: 10.1159/000330017

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  20 in total

1.  Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease.

Authors:  Géraldine Poisnel; Anne-Sophie Hérard; Nadine El Tannir El Tayara; Emmanuel Bourrin; Andreas Volk; Frank Kober; Benoit Delatour; Thierry Delzescaux; Thomas Debeir; Thomas Rooney; Jésus Benavides; Philippe Hantraye; Marc Dhenain
Journal:  Neurobiol Aging       Date:  2011-11-12       Impact factor: 4.673

2.  Familial Alzheimer's Disease Mutations within the Amyloid Precursor Protein Alter the Aggregation and Conformation of the Amyloid-β Peptide.

Authors:  Asa Hatami; Sanaz Monjazeb; Saskia Milton; Charles G Glabe
Journal:  J Biol Chem       Date:  2017-01-03       Impact factor: 5.157

3.  Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytes.

Authors:  Elaine Delvaux; Karen Bentley; Victoria Stubbs; Marwan Sabbagh; Paul D Coleman
Journal:  Neurobiol Aging       Date:  2013-01-05       Impact factor: 4.673

Review 4.  Network abnormalities and interneuron dysfunction in Alzheimer disease.

Authors:  Jorge J Palop; Lennart Mucke
Journal:  Nat Rev Neurosci       Date:  2016-11-10       Impact factor: 34.870

Review 5.  Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?

Authors:  Jacques Fantini; Henri Chahinian; Nouara Yahi
Journal:  Protein Sci       Date:  2020-07-13       Impact factor: 6.725

Review 6.  β-Amyloid peptides and amyloid plaques in Alzheimer's disease.

Authors:  Gunnar K Gouras; Tomas T Olsson; Oskar Hansson
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

Review 7.  Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.

Authors:  Ann D Cohen; Gil D Rabinovici; Chester A Mathis; William J Jagust; William E Klunk; Milos D Ikonomovic
Journal:  Adv Pharmacol       Date:  2012

8.  Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation.

Authors:  L Kulic; J McAfoose; T Welt; C Tackenberg; C Späni; F Wirth; V Finder; U Konietzko; M Giese; A Eckert; K Noriaki; T Shimizu; K Murakami; K Irie; S Rasool; C Glabe; C Hock; R M Nitsch
Journal:  Transl Psychiatry       Date:  2012-11-13       Impact factor: 6.222

Review 9.  Applications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative Diseases.

Authors:  Wenbin Wan; Lan Cao; Bill Kalionis; Shijin Xia; Xiantao Tai
Journal:  Stem Cells Int       Date:  2015-07-09       Impact factor: 5.443

10.  Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer's disease: analysis of Osaka mutation-knockin mice.

Authors:  Tomohiro Umeda; Tetsuya Kimura; Kayo Yoshida; Keizo Takao; Yuki Fujita; Shogo Matsuyama; Ayumi Sakai; Minato Yamashita; Yuki Yamashita; Kiyouhisa Ohnishi; Mamiko Suzuki; Hiroshi Takuma; Tsuyoshi Miyakawa; Akihiko Takashima; Takashi Morita; Hiroshi Mori; Takami Tomiyama
Journal:  Acta Neuropathol Commun       Date:  2017-07-31       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.